Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Zach System is committed to providing Highly Customized Solutions for all your Development Programs.
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Zach System is committed to providing Highly Customized Solutions for all your Development Programs.
Certificate Number : CEP 2020-370 - Rev 03
Status : Valid
Issue Date : 2024-06-12
Type : Chemical
Substance Number : 1425
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Taste Masking
Thickeners and Stabilizers
Coating Systems & Additives
Parenteral
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
13 Nov 2024
Reply
23 Jul 2024
Reply
13 Jul 2024
Reply
02 Jul 2024
Reply
10 Apr 2024
Reply
05 Oct 2023
Reply
11 May 2023
Reply
23 Feb 2023
Reply
31 May 2022
Reply
18 Feb 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
EDQM
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Fosfomycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosfomycin, including repackagers and relabelers. The FDA regulates Fosfomycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosfomycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosfomycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosfomycin supplier is an individual or a company that provides Fosfomycin active pharmaceutical ingredient (API) or Fosfomycin finished formulations upon request. The Fosfomycin suppliers may include Fosfomycin API manufacturers, exporters, distributors and traders.
click here to find a list of Fosfomycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fosfomycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Fosfomycin active pharmaceutical ingredient (API) in detail. Different forms of Fosfomycin DMFs exist exist since differing nations have different regulations, such as Fosfomycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fosfomycin DMF submitted to regulatory agencies in the US is known as a USDMF. Fosfomycin USDMF includes data on Fosfomycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fosfomycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fosfomycin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fosfomycin Drug Master File in Japan (Fosfomycin JDMF) empowers Fosfomycin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fosfomycin JDMF during the approval evaluation for pharmaceutical products. At the time of Fosfomycin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fosfomycin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fosfomycin Drug Master File in Korea (Fosfomycin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fosfomycin. The MFDS reviews the Fosfomycin KDMF as part of the drug registration process and uses the information provided in the Fosfomycin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fosfomycin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fosfomycin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fosfomycin suppliers with KDMF on PharmaCompass.
A Fosfomycin CEP of the European Pharmacopoeia monograph is often referred to as a Fosfomycin Certificate of Suitability (COS). The purpose of a Fosfomycin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fosfomycin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fosfomycin to their clients by showing that a Fosfomycin CEP has been issued for it. The manufacturer submits a Fosfomycin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fosfomycin CEP holder for the record. Additionally, the data presented in the Fosfomycin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fosfomycin DMF.
A Fosfomycin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fosfomycin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fosfomycin suppliers with CEP (COS) on PharmaCompass.
A Fosfomycin written confirmation (Fosfomycin WC) is an official document issued by a regulatory agency to a Fosfomycin manufacturer, verifying that the manufacturing facility of a Fosfomycin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fosfomycin APIs or Fosfomycin finished pharmaceutical products to another nation, regulatory agencies frequently require a Fosfomycin WC (written confirmation) as part of the regulatory process.
click here to find a list of Fosfomycin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosfomycin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosfomycin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosfomycin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosfomycin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosfomycin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosfomycin suppliers with NDC on PharmaCompass.
Fosfomycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosfomycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosfomycin GMP manufacturer or Fosfomycin GMP API supplier for your needs.
A Fosfomycin CoA (Certificate of Analysis) is a formal document that attests to Fosfomycin's compliance with Fosfomycin specifications and serves as a tool for batch-level quality control.
Fosfomycin CoA mostly includes findings from lab analyses of a specific batch. For each Fosfomycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosfomycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosfomycin EP), Fosfomycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosfomycin USP).
LOOKING FOR A SUPPLIER?
Comment (1)
